Compare XMTR & MMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XMTR | MMED |
|---|---|---|
| Founded | 2013 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.7B |
| IPO Year | 2021 | 2025 |
| Metric | XMTR | MMED |
|---|---|---|
| Price | $120.06 | $18.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 16 |
| Target Price | ★ $124.64 | $25.33 |
| AVG Volume (30 Days) | 856.0K | ★ 8.6M |
| Earning Date | 11-03-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.95 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $686,631,000.00 | ★ $3,102,000,000.00 |
| Revenue This Year | $37.26 | $10.76 |
| Revenue Next Year | $21.51 | $8.51 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.87 | 14.25 |
| 52 Week Low | $35.86 | $10.65 |
| 52 Week High | $127.49 | $24.43 |
| Indicator | XMTR | MMED |
|---|---|---|
| Relative Strength Index (RSI) | 63.68 | 47.68 |
| Support Level | $83.30 | $16.61 |
| Resistance Level | N/A | $20.40 |
| Average True Range (ATR) | 9.42 | 0.95 |
| MACD | 2.18 | 0.02 |
| Stochastic Oscillator | 81.46 | 45.31 |
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.
While MiniMed recently became an independent company again, it began in the 1980s as an upstart pioneer in developing and commercializing insulin pump therapy. Medtronic acquired MiniMed in 2001 and then spun it out in 2026 (though Medtronic still owns roughly 90% of MiniMed shares, which will be relayed to its shareholders as a tax-free distribution in the foreseeable future). MiniMed is the leader in traditional, tubed insulin pumps and also offers continuous glucose monitors, smart insulin pens, and other consumables.